United States · Bill · HR
H.R. 3093 (118th)
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2023
Introduced
5 May 2023
Last action
12 May 2023 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Hoyle, Val T. [D-OR-4], Rep. Doggett, Lloyd [D-TX-37], Rep. Cohen, Steve [D-TN-9], Rosa DeLauro, Jesús García, Raúl Grijalva, Rep. Jayapal, Pramila [D-WA-7], Marcy Kaptur, Rep. Khanna, Ro [D-CA-17], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Pingree, Chellie [D-ME-1], Rep. Pocan, Mark [D-WI-2], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Stansbury, Melanie A. [D-NM-1], Jill Tokuda, Rep. Casar, Greg [D-TX-35], Mark Takano, Rep. Magaziner, Seth [D-RI-2], Rep. Tlaib, Rashida [D-MI-12]
Subjects
Healthcare
Source updated
24 July 2024
Summary
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 202 3 This bill requires companies that receive federal funding for research (or a license of the rights to a patent or regulatory test data) for a biomedical product or service to agree to set reasonable prices for the resulting biomedical product or service. The Department of Health and Human Services (HHS) must determine a reasonable price based on a formula that ensures the U.S. price for the product or service is not more than the median price for the product or service in Canada and six other reference countries with, based on specified criteria, large economies and high incomes. Companies entering these agreements also must report to HHS certain financial information related to the biomedical product or service involved.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
5 May 2023
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
5 May 2023
Introduced
Introduced in House
Source: IntroReferral
5 May 2023
Introduced
Introduced in House
Source: IntroReferral
12 May 2023
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 5 May 2023 · Official file
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 5 May 2023
Introduced in House (PDF)
Introduced in House · EN · 5 May 2023
Introduced in House
summary · EN · 5 May 2023
Sponsors
- Rep. Hoyle, Val T. [D-OR-4] · D · Sponsor
- Rep. Doggett, Lloyd [D-TX-37] · D · Sponsor
- Rep. Cohen, Steve [D-TN-9] · D · Sponsor
- Rosa DeLauro · D · Sponsor
- Jesús García · D · Sponsor
- Raúl Grijalva · D · Sponsor
- Rep. Jayapal, Pramila [D-WA-7] · D · Sponsor
- Marcy Kaptur · D · Sponsor
- Rep. Khanna, Ro [D-CA-17] · D · Sponsor
- Del. Norton, Eleanor Holmes [D-DC-At Large] · D · Sponsor
- Rep. Pingree, Chellie [D-ME-1] · D · Sponsor
- Rep. Pocan, Mark [D-WI-2] · D · Sponsor
- Rep. Schakowsky, Janice D. [D-IL-9] · D · Sponsor
- Rep. Stansbury, Melanie A. [D-NM-1] · D · Sponsor
- Jill Tokuda · D · Sponsor
- Rep. Casar, Greg [D-TX-35] · D · Cosponsor
- Mark Takano · D · Cosponsor
- Rep. Magaziner, Seth [D-RI-2] · D · Cosponsor
- Rep. Tlaib, Rashida [D-MI-12] · D · Cosponsor
- · hsif00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/house-bill/3093
- Open data entity: https://api.congress.gov/v3/bill/118/hr/3093
- us · 118-hr-3093 · source updated 24 July 2024